trial · primary record
Sutetinib Maleate Capsule
Non-small Cell Lung Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 66 |
| Primary completion | 2028-12 |
| Primary endpoint | Objective Response Rate (ORR) |
| Registry ID | NCT06010329 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:06.252Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06010329
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.